Trial intelligence / Profile preview

CTI-01 in Cardiac Surgery with CPB

NCT00107666Phase 2Terminated

Sponsor
Critical Therapeutics, Inc.
Start
Apr 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ethyl pyruvate in postoperative complications, sponsored by Critical Therapeutics, Inc.. Started Apr 2005; status: terminated.

02

Drugs

ethyl pyruvate
03

Conditions

postoperative complications

Beyond the preview

Go deeper on NCT00107666.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00107666.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call